FIRST SALES!!!!!!!!!
LAYTON, Utah--(BUSINESS WIRE)--June 19, 2000--Computerized Thermal Imaging, Inc. (CTI) (OTC symbol:
COII) announced today the sale of 10 CTI breast cancer imaging systems to a Latin American consortium based in
Mexico City for $5 million.
This consortium, Computerized Thermal Imaging International, and CTI had previously announced an agreement to
deploy 100 CTI breast cancer imaging units in Latin America. This initial purchase order was accompanied by a down
payment of $1.75 million, with the balance due upon delivery of the systems.
"This is a very significant event in our corporate history," stated David Packer, President and COO. "It represents the
first sale of our revolutionary breast cancer imaging system and our first significant revenues. This achievement is the result
of our unwavering commitment to bring this product to market successfully. Our recent acquisition of Bales Scientific will
greatly enhance both production and support. We will now begin production as well as total implementation of the
domestic and international product support infrastructure."
CTI is seeking FDA approval for use of its Computerized Thermal Imaging System in the United States as an
adjunctive diagnostic test to mammography and clinical examination for the detection of breast cancer. The test is simple,
painless, and involves no radiation, breast compression, electrodes, electrical current, or skin contact. CTI also recently
announced evaluation of their technology for new occupational medicine applications.
Computerized Thermal Imaging, Inc. is in business to improve the quality of life through superior diagnostics.
Information about CTI can be found on the Internet at www.cti-net.com or by calling CTI Public Affairs at (801)
926-1113. |
